ArcDia Receives Frost & Sullivan award for Point of Care Product Leadership

Frost & Sullivan granted the award for ArcDia’s mariPOC product line. Frost & Sullivan has recognised mariPOC® as the leading product in rapid diagnostics testing of acute respiratory infectious diseases. ArcDia’s mariPOC® is an automated continuous-feed analyser, which allows prompt detection of most common viral and bacterial pathogens responsible for influenza-like infections and tonsillitis both in POC and laboratory settings. 

According to Frost & Sullivan, mariPOC® provides a range of benefits which can boost customer value in hospitals and primary care centres. mariPOC product is easy-to-use and it delivers results in 20 minutes, thereby eliminating repeated patient visits. Frost & Sullivan’s market analysis suggests that mariPOC® has the potential to replace conventional rapid and laboratory antigen tests. mariPOC® can easily be connected to laboratory information systems making it one of the most compelling offerings on the market today.

mariPOC was launched in 2010 and It has received an excellent response from doctors and patients using the test system in hospitals. Not surprisingly, ArcDia has been able to significantly expand its sales network to cover 26 countries in Europe and the Middle East. More new test applications are to be introduced by ArcDia to support market requirements to meet unmet clinical needs.

“Receiving the Frost & Sullivan Product Leadership Award is proof that our mariPOC respiratory infectious diseases system is recognized by professionals,” says Jesper Floyd Kristiansen, Vice President of Sales & Marketing of ArcDia. “2013 was the year of international break through for mariPOC® in terms of expansion of our distribution network. Interestingly, this leadership award overlaps in timing with ArcDia’s launch of the world’s first antigen test for Bocavirus, both of which show leadership in product innovation”, says Kristiansen.